Targeting of antigens to skin dendritic cells: Possibilities to enhance vaccine efficacy

Immunology and Cell Biology

Volumn 88, Issue 4, 2010, Pages 424-430

  Romani, Nikolaus ^a,b   Thurnher, Martin ^a,b   Idoyaga, Juliana ^c   Steinman, Ralph M ^c   Flacher, Vincent ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Center for Personalized Cancer Medicine GmbH   (Austria)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Antigen targeting; Dendritic cells; Immunogenicity; Langerhans cells; Langerin CD207; Vaccine

Indexed keywords

CD14 ANTIGEN; CD205 ANTIGEN; CD209 ANTIGEN; DEC 205 ANTIBODY; LANGERIN; LANGERIN ANTIBODY; LYMPHOCYTE ANTIBODY; LYMPHOCYTE ANTIGEN; OVALBUMIN; T6 ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DERMIS; DRUG EFFICACY; EXPERIMENTAL NEOPLASM; HUMAN; IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; LANGERHANS CELL; NONHUMAN; REVIEW; SKIN CELL; STEADY STATE; VACCINATION;

ANIMALS; ANTIGENS, CD; HUMANS; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; VACCINES;

HARNESS;

EID: 77952237095     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.39     Document Type: Review

References (81)

1. Steinman RM. Dendritic cells in vivo: a key target for a new vaccine science. Immunity 2008; 29: 319-324.
2. Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 2006; 124: 849-863.
3. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449: 419-426.
4. Steinman RM. Dendritic cells and vaccines. Proc (Bayl Univ Med Cent) 2008; 21: 3-8.
5. Ueno H, Schmitt N, Klechevsky E, Pedroza-Gonzalez A, Matsui T, Zurawski G et al. Harnessing human dendritic cell subsets for medicine. Immunol Rev 2010; 234: 199-212.
6. Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008; 7: 1201-1214.
7. Warger T, Schild H, Rechtsteiner G. Initiation of adaptive immune responses by transcutaneous immunization. Immunol Lett 2007; 109: 13-20.
8. Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 2008; 371: 2019-2025.
9. Stoitzner P, Sparber F, Tripp CH. Langerhans cells as targets for immunotherapy against skin cancer. Immunol Cell Biol 2010; 88: 431-437.
10. Dupuis M, Murphy TJ, Higgins D, Ugozzoli M, Van Nest G, Ott G et al. Dendritic cells internalize vaccine adjuvant after intramuscular injection. Cell Immunol 1998; 186: 18-27.
11. Casares S, Inaba K, Brumeanu TD, Steinman RM, Bona CA. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J Exp Med 1997; 186: 1481-1486.
12. Hart DNJ, Fabre JW. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med 1981; 154: 347-361.
13. Lenz A, Heine M, Schuler G, Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest 1993; 92: 2587-2596.
14. Dupasquier M, Prens EP, Leenen PJM. Dermal mononuclear phagocytes. In: Saeland S (ed.). Recent Advances in Skin Immunology. Research Signpost: Trivandrum, Kerala, India, 2008, 75-104.
15. Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008; 29: 497-510.
16. Angel CE, Lala A, Chen CJ, Edgar SG, Ostrovsky LL, Dunbar PR. CD14+ antigenpresenting cells in human dermis are less mature than their CD1a+ counterparts. Int Immunol 2007; 19: 1271-1279.
17. Zaba LC, Krueger JG, Lowes MA. Resident and inflammatory dendritic cells in human skin. J Invest Dermatol 2009; 129: 302-308.
18. Zaba LC, Fuentes-Duculan J, Steinman RM, Krueger JG, Lowes MA. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest 2007; 117: 2517-2525.
19. Dupasquier M, Stoitzner P, Van Oudenaren A, Romani N, Leenen PJM. Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J Invest Dermatol 2004; 123: 876-879.
20. Poulin LF, Henri S, de Bovis B, Devilard E, Kissenpfennig A, Malissen B. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 2007; 204: 3119-3131.
21. Ginhoux F, Collin M, Bogunovic M, Abel M, Leboef M, Helft J et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 2007; 204: 3133-3146.
22. Bursch LS, Wang L, Igyarto B, Kissenpfennig A, Malissen B, Kaplan DH et al. Identification of a novel population of langerin+ dendritic cells. J Exp Med 2007; 204: 3147-3156.
23. Romani N, Clausen BE, Stoitzner P. Langerhans cells & more: Langerin-expressing dendritic cell subsets in the skin. Immunol Rev 2010; 234: 120-141.
24. Lowes MA, Chamian F, Abello MV, Fuentes-Duculan J, Lin SL, Nussbaum R et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 2005; 102: 19057-19062.
25. Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 1996; 106: 446-453.
26. Palamara F, Meindl S, Holcmann M, Lü hrs P, Stingl G, Sibilia M. Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J Immunol 2004; 173: 3051-3061.
27. Ebner S, Ehammer Z, Holzmann S, Schwingshackl P, Forstner M, Stoitzner P et al. Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int Immunol 2004; 16: 877-887.
28. Romani N, Ebner S, Flacher V, Tripp CH, Heufler C, Clausen BE et al. Langerhans cells-dendritic cells of the epidermis and other epithelia. In: Saeland S (ed.). Recent Advances in Skin Immunology. Research Signpost: Trivandrum, Kerala, India, 2008, 27-73.
29. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 2008; 8: 935-947.
30. Caux C, Massacrier C, Vanbervliet B, Dubois B, Durand I, Cella M et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor a. 2. Functional analysis. Blood 1997; 90: 1458-1470.
31. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhé C, Perrin P, Romani N et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005; 22: 643-654.
32. Ueno H, Schmitt N, Palucka AK, Banchereau J. Dendritic cells and humoral immunity in humans. Immunol Cell Biol 2010; 88: 376-380.
33. Ratzinger G, Baggers J, de Cos MA, Yuan J, Dao T, Reagan JL et al. Mature human Langerhans cells derived from CD34+ hemopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J Immunol 2004; 173: 2780-2791.
34. Ebner S, Nguyen VA, Forstner M, Wang YH, Wolfram D, Liu Y-J et al. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen presenting cells that induce pro-allergic T cells. J Allergy Clin Immunol 2007; 119: 982-990.
35. Stoitzner P, Green LK, Jung JY, Price KM, Tripp CH, Malissen B et al. Tumor immunotherapy by epicutaneous immunization requires Langerhans cells. J Immunol 2008; 180: 1991-1998.
36. Kaplan DH, Kissenpfennig A, Clausen BE. Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol 2008; 38: 2369-2376.
37. Clausen BE, Kel JM. Langerhans cells: critical regulators of skin immunity? Immunol Cell Biol 2010; 88: 351-360.
38. Figdor CG, Van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002; 2: 77-84. (Pubitemid 37323231)
39. Idoyaga J, Cheong C, Suda K, Suda N, Kim JY, Lee H et al. The Langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and MHC II products in vivo. J Immunol 2008; 180: 3647-3650.
40. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194: 769-779.
41. Nchinda G, Kuroiwa J, Oks M, Trumpfheller C, Park CG, Huang Y et al. The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J Clin Invest 2008; 118: 1427-1436.
42. Trumpfheller C, Caskey M, Nchinda G, Longhi MP, Mizenina O, Huang Y et al. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc Natl Acad Sci USA 2008; 105: 2574-2579.
43. Wang B, Kuroiwa JM, He LZ, Charalambous A, Keler T, Steinman RM. The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells. Ann N Y Acad Sci 2009; 1174: 6-17.
44. Mahnke K, Qian YJ, Fondel S, Brueck J, Becker C, Enk AH. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice. Cancer Res 2005; 65: 7007-7012.
45. Choi JH, Do Y, Cheong C, Koh H, Boscardin SB, Oh YS et al. Identification of antigenpresenting dendritic cells in mouse aorta and cardiac valves. J Exp Med 2009; 206: 497-505.
46. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 2000; 151: 673-683.
47. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002; 196: 1627-1638.
48. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685-711.
49. Bruder D, Westendorf AM, Hansen W, Prettin S, Gruber AD, Qian YJ et al. On the edge of autoimmunity-T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 2005; 54: 3395-3401.
50. Mukhopadhaya A, Hanafusa T, Jarchum I, Chen YG, Iwai Y, Serreze DV et al. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc Natl Acad Sci USA 2008; 105: 6374-6379.
51. Yamazaki S, Dudziak D, Heidkamp GF, Fiorese C, Bonito AJ, Inaba K et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J Immunol 2008; 181: 6923-6933.
52. Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii SI, Soares H et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 2004; 199: 815-824.
53. Boscardin SB, Hafalla JCR, Masilamani RF, Kamphorst AO, Zebroski HA, Rai U et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med 2006; 203: 599-606.
54. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007; 315: 107-111.
55. Yamazaki S, Steinman RM. Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells. J Dermatol Sci 2009; 54: 69-75.
56. Bozzacco L, Trumpfheller C, Siegal FP, Mehandru S, Markowitz M, Carrington M et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci USA 2007; 104: 1289-1294.
57. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000; 12: 71-81.
58. Cheong C, Idoyaga J, Do Y, Pack M, Park SH, Lee H et al. Production of monoclonal antibodies that recognize the extracellular domain of mouse Langerin/CD207. J Immunol Methods 2007; 324: 48-62.
59. Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, Parish IA et al. Crosspresentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004; 199: 9-26.
60. Idoyaga J, Suda N, Suda K, Park CG, Steinman RM. Antibody to Langerin/CD207 localizes large numbers of CD8a+ dendritic cells to the marginal zone of mouse spleen. Proc Natl Acad Sci USA 2009; 106: 1524-1529.
61. Farrand KJ, Dickgreber N, Stoitzner P, Ronchese F, Petersen TR, Hermans IF. Langerin+CD8a+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens. J Immunol 2009; 183: 7732-7742.
62. Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Teh JS, Lo JCY et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008; 112: 3264-3273.
63. Lahoud MH, Proietto AI, Ahmet F, Kitsoulis S, Eidsmo L, Wu L et al. The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses. J Immunol 2009; 182: 7587-7594.
64. Caminschi I, Lahoud MH, Shortman K. Enhancing immune responses by targeting antigen to dendritic cells. Eur J Immunol 2009; 39: 931-938.
65. Dickgreber N, Stoitzner P, Bai Y, Price KM, Farrand KJ, Manning K et al. Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy. J Immunol 2009; 182: 1260-1269.
66. Tacken PJ, de Vries IJ, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol 2007; 7: 790-802.
67. Flacher V, Tripp CH, Stoitzner P, Haid B, Ebner S, Del Frari B et al. Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. J Invest Dermatol 2010; 130: 755-762.
68. Ariizumi K, Shen GL, Shikano S, Xu S, Ritter III R, Kumamoto T et al. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem 2000; 275: 20157-20167.
69. Ariizumi K, Shen GL, Shikano S, Ritter III R, Zukas P, Edelbaum D et al. Cloning of a second dendritic cell-associated C-type lectin (Dectin-2) and its alternatively spliced isoforms. J Biol Chem 2000; 275: 11957-11963.
70. Witmer-Pack MD, Valinsky J, Olivier W, Steinman RM. Quantitation of surface antigens on cultured murine epidermal Langerhans cells: rapid and selective increase in the level of surface MHC products. J Invest Dermatol 1987; 90: 387-394.
71. Inaba K, Swiggard WJ, Inaba M, Meltzer J, Mirza A, Sasagawa T et al. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell Immunol 1995; 163: 148-156.
72. Turville SG, Cameron PU, Handley A, Lin G, Pohlmann S, Doms RW et al. Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 2002; 3: 975-983.
73. Delneste Y, Magistrelli G, Gauchat JF, Haeuw JF, Aubry JP, Nakamura K et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002; 17: 353-362.
74. Angel CE, George E, Brooks AE, Ostrovsky LL, Brown TL, Dunbar PR. Cutting edge: CD1a+ antigen-presenting cells in human dermis respond rapidly to CCR7 ligands. J Immunol 2006; 176: 5730-5734.
75. Aberer W, Kruisbeek AM, Shimada S, Katz SI. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells. J Immunol 1986; 136: 830-836.
76. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2: 361-367.
77. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009; 206: 2937-2946.
78. Carter RW, Thompson C, Reid DM, Wong SY, Tough DF. Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J Immunol 2006; 177: 2276-2284.
79. Flacher V, Sparber F, Tripp CH, Romani N, Stoitzner P. Targeting of epidermal Langerhans cells with antigenic proteins-attempts to harness their properties for immunotherapy. Cancer Immunol Immunother 2009; 58: 1137-1147.
80. Holzmann S, Tripp CH, Schmuth M, Janke K, Koch F, Saeland S et al. A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J Invest Dermatol 2004; 122: 1165-1174.
81. Tagliani E, Guermonprez P, Sepulveda J, Lopez-Bravo M, Ardavin C, Amigorena S et al. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8a+ dendritic cells. J Immunol 2008; 180: 3201-3209.